Clinical Trials Logo

Post-Traumatic Stress Disorders clinical trials

View clinical trials related to Post-Traumatic Stress Disorders.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT02384369 Not yet recruiting - Clinical trials for Stress Disorders, Post-Traumatic

Trial of Oral SNC-102 in Subjects With Combat-Related Posttraumatic Stress Disorder

PTSD
Start date: June 2016
Phase: Phase 2
Study type: Interventional

This is a randomized, double-blind, placebo-controlled study of SNC-102 in adult subjects with cPTSD, added to pre-existing treatment that includes prazosin with or without other psychotropic drugs. Subjects will be treated with SNC-102 tablets or matching placebo on a BID basis for 8 weeks. Subjects will be evaluated for the symptoms of combat-related posttraumatic stress disorder (cPTSD) as measured by the Clinician Administered PTSD Scale (CAPS-5), compared with the response to placebo.

NCT ID: NCT00269139 Not yet recruiting - Clinical trials for Borderline Personality Disorder

Outcome of Crisis Intervention for Subjects With Borderline Personality Disorder or Post-Traumatic Stress Disorder

Start date: n/a
Phase: Phase 1
Study type: Interventional

Dr. Laddis will test a hypothesis about the nature and the management of behavioral crises in patients with borderline personality disorder (BPD) or post-traumatic stress disorder (PTSD). The term "behavioral crisis" is used strictly for periods of uncontrollable urges to repeat mental or outward activity, e.g., flashbacks, cutting, binging on food, drugs or sex, with no intervals to rethink one's priorities or to consider others' direction. The clinical hypothesis states, in two steps, that: 1. the perception of a life crisis precedes and then underlies every behavioral crisis; 2. the behavioral crisis resolves promptly and all symptoms end if the clinicians engage the patient about his management of the life crisis that underlies the symptoms.